Kava kava

Kava Extract, Powder

Products
1
NIH LiverTox — hepatotoxicity
Category A · Well-established cause
About LiverTox →

LiverTox Category A (well-established cause). Severe idiosyncratic hepatitis including liver failure / transplant. Banned or restricted in Germany, UK, France, Switzerland.

LiverTox record (NIH NCBI Bookshelf) →
Label dose distribution · 1 labeled products
Min
350 mg
Typical
350 mg
Max
350 mg
Other forms of Kava kava

25 sibling forms

Distinct chemical forms sharing the same parent nutrient. Different UNIIs, different bioavailability, different effects — never collapsed.

Top brands carrying Kava Extract, Powder

15 brands rolled up

Products containing Kava Extract, Powder

1 in catalog